News
06/02/2025
Virginia Tech researchers find promise in a new peptide drug to combat a deadly brain cancer
A lab-designed molecule developed and extensively studied by scientists with Virginia Tech’s Fralin Biomedical Research Institute at VTC could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer. In a study published May 16 in Cell Death and Disease, researchers identified a previously unknown trait of cancer cells that …
05/28/2025
Brandy Salmon named Virginia Tech’s first vice president for innovation and partnerships
Brandy Salmon, who since 2017 has led Virginia Tech teams focused on connecting the university with corporations, foundations, and alumni worldwide has been named the university’s first vice president for innovation and partnerships. “True collaboration between higher education, government, and industry is essential for success in today’s evolving landscape,” said Virginia Tech President Tim Sands. …
05/28/2025
Avera Joins Civica to Help Minimize Risk of Drug Shortages
Civica, a nonprofit pharmaceutical company created to prevent and mitigate drug shortages, announced today that Avera, a leading nonprofit healthcare provider in the Upper Midwest United States, has joined the company in helping protect patients from the impact of drug shortages of essential generic sterile injectable medicines. Drug shortages are a persistent challenge to the …
05/23/2025
CEL-SCI Announces Closing of Public Offering
CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the closing of its underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $2.50 per share. Total gross proceeds from the offering, before deducting the underwriting discount and other offering expenses, …
05/21/2025
Virginia Western Community College and James Madison University announce articulation agreement for biotechnology students
Virginia Western Community College and James Madison University signed an articulation agreement on Monday, May 19, that will result in a seamless transition for students focusing on the field of biotechnology. Virginia Western students completing the Associate of Science (A.S.) degree in Science with a major in Biotechnology and meeting all requirements will be guaranteed …
05/21/2025
Lighthouse Labs rebrands as Lighthouse Network, shifts focus to long-term founder development
Longtime Richmond accelerator Lighthouse Labs is rebranding to better reflect its commitment to startup founders. The organization will now be known as Lighthouse Network and will make a “renewed focus” on long-term, human-centered development of founders, it said in its announcement. “We’ve always believed that when founders thrive, so do their companies,” Debbie Irwin, who …
05/20/2025
BIO-CAT Gains Organic Certification to Meet the Growing Demands of Consumers
As consumer demand for clean-label, organic, and non-GMO products continues to surge, the pressure is mounting on ingredient suppliers to meet stringent certification standards and scale production accordingly. As the “food as medicine” movement gains traction and shoppers report increasing their purchases of natural (23%) and organic (22%) products over the last six months, the …
05/14/2025
Civica to start Chesterfield lab construction this summer, eyes Petersburg plant expansion
Nearly three years after announcing plans to build a laboratory in Chesterfield to support its manufacturing operations in Petersburg, Civica Rx is readying plans to kick off the project’s construction. The Utah-based nonprofit drugmaker said it will break ground this summer on a 50,000-square-foot facility at 11731 Meadowville Lane, in the Meadowville Technology Park near Chester. …
05/07/2025
Adial Pharmaceuticals raises $2.75M
Glen Allen biopharma company Adial Pharmaceuticals Inc. (NASDAQ: ADIL) has raised $2.75 million from an institutional investor. The company, which specializes in therapies for addiction and related disorders, said it will use the new funding for working capital and general corporate purposes. The name of the investor was not disclosed, but Adial said a “health …
05/07/2025
Adovate Granted New U.S. Patent for Therapeutic Uses of A2B Receptor Antagonists
Adovate, LLC (“Adovate” or the “Company”), a biopharmaceutical company developing novel therapeutics targeting adenosine receptors involved in major diseases, today announced that Patent Number 12,269,828 B2 was issued by the United States Patent and Trademark Office. This newly issued patent covers therapeutic uses of the Company’s lead molecule ADO-5030 and thousands of other novel molecules …
04/29/2025
ODU breaks ground on $184M biosciences building
Old Dominion University on Monday broke ground on the biggest capital construction project in the 95-year-old university’s history — a new biological sciences building. The planned five-story, 162,586 square-foot building will be located on ODU‘s campus in Norfolk, near the university’s Oceanography and Mills Godwin Life Sciences buildings. ODU spokesperson Jonah Ross Grinkewitz said the …
04/29/2025
Compremium AG Appoints Dr. Kolaleh Eskandanian to Lead New Division of Pediatrics and Special Populations
Dr. Eskandanian, a global leader in pediatric innovation, joins Compremium from Children’s National Hospital in Washington, D.C., where she most recently served as Vice President and Chief Innovation Officer, Executive Director of the Sheikh Zayed Institute for Pediatric Surgical Innovation, and founding executive of Innovation Ventures. Her appointment marks a strategic milestone in Compremium’s expansion …
04/24/2025
SSI Diagnostica Group Acquires Breath Test Maker Gulf Coast Scientific
Infectious disease diagnostics firm SSI Diagnostica Group said on Thursday that it has acquired Florida-based breath testing firm Gulf Coast Scientific for an undisclosed sum. Gulf Coast Scientific is a developer of urea breath tests for Helicobacter pylori infection, which is associated with conditions including chronic gastritis and gastric cancer. SSID Group said that the …
04/23/2025
Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board
Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova’s board, and the successful completion of a new round of growth equity capital. These developments support Grenova’s strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories …
04/22/2025
Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America
Phlow Corp., a leading pharmaceutical contract development and manufacturing organization (CDMO) in America, announced a significant expansion in its analytical capabilities, use of artificial intelligence (AI), workforce, and domestic infrastructure. Marking a period of exceptional growth and momentum, Phlow has more than doubled in size and now employs over 90+ highly skilled scientists and professionals …
04/22/2025
ATCC Announces New Executive Leadership Appointments
ATCC, the world’s premier biological materials management and standards organization, today announced several new leadership appointments. Rebecca Bradford, MBA, has been promoted to the role of senior vice president of Government Programs, ATCC Federal Solutions (AFS); Manoj Menon, PhD, has joined the company as chief operating officer; and Rupali Lach was appointed vice president of Commercial Operations. …
04/14/2025
Novonesis Poised to Accelerate National Security Commission Priorities on Biotechnology
Novonesis, a world-leading biosolutions company, recognizes the importance of the National Security Commission on Emerging Biotechnology (NSCEB) report as a pivotal milestone in charting a bold path forward for American biotechnology. Novonesis applauds the NSCEB’s deep investigation of unlocking U.S.-led biotechnology in the Fourth Industrial Revolution. As a global force in industrial biotech with more …
04/11/2025
WND Ventures Charts New Direction to Accelerate Innovation in Construction Tech
Following a compelling debut of its refreshed vision at BuiltWorlds Venture West, WND Ventures announced a transformative new approach to corporate venture capital in the AEC industry, designed to deepen relationships with startups with the potential to create new efficiency in construction and deliver value throughout project lifecycles. Backed by DPR Construction and more than …
04/10/2025
UVA Alum, a Top Medical Researcher, Will Lead Manning Institute
The University of Virginia announced it has hired an alumnus known for fostering collaborations among universities, the government and private industry to lead the Paul and Diane Manning Institute of Biotechnology and to animate the institute’s ambitious plans, including translating laboratory discoveries to therapies and treatments that improve life. Mark T. Esser, a vice president …
04/02/2025
VCU startup wins $800k grant to propel its infection-fighting surgical gel
With an innovation that could advance brain and spinal surgeries, a Virginia Commonwealth University startup has received an $800,000 state grant to support development of its infection-fighting gel. Pascal Medical Corp. is one of four grant recipients to receive awards from Virginia Catalyst, a nonprofit created by the General Assembly and funded by the state’s general …
04/02/2025
Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on the development and commercialization of therapeutic products that treat rare and orphan diseases, today announces additional highly positive clinical data from its ongoing Investigator Pediatric Netherton Syndrome (NS) study. After 6 weeks of continued whole body application …
04/02/2025
Charlottesville Angel Network Celebrates 10 Years, Surpasses $20 Million in Investments
The Charlottesville Angel Network (CAN), a group of accredited investors dedicated to supporting early-stage ventures, proudly marks its 10th anniversary this month. Since its inception, CAN angel investor members have invested more than $20 million in nearly 80 startups, fostering innovation both locally and beyond. Reflecting on a decade of achievements, CAN has realized returns …
04/02/2025
BACE credential helps Virginia Western Biotechnology students show readiness for employment
In a short time, Virginia Western’s Biotechnology Program has established a reputation as an accessible place for students to start from any point of their science journey and get thorough, hands-on experience with equipment and techniques required to work as lab technicians. But for those who decide that yes, this is the field for them, …
04/02/2025
Caretaker Medical Receives Inaugural Healthcare Tech Innovation Award and $200,000 Grant from Medical Society of D.C.
Caretaker Medical is honored to announce it has been awarded the Healthcare Technology Innovation Award, along with a $200,000 grant, from the Medical Society of the District of Columbia (MSDC) at the 5th annual Capital Healthcare Honors Gala. This prestigious award, presented on March 26, 2025, recognizes Caretaker Medical’s groundbreaking work in advancing wireless patient …
04/01/2025
ReAlta Life Sciences Announces Appointment of Distinguished Immunologist, Laurie Glimcher, M.D., to Board of Directors
ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, announced the appointment of Laurie Glimcher, M.D., to its Board of Directors, effective immediately. Dr. Glimcher is a distinguished immunologist widely renowned for her work in cancer …